BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fathi Maroufi N, Taefehshokr S, Rashidi MR, Taefehshokr N, Khoshakhlagh M, Isazadeh A, Mokarizadeh N, Baradaran B, Nouri M. Vascular mimicry: changing the therapeutic paradigms in cancer. Mol Biol Rep 2020;47:4749-65. [PMID: 32424524 DOI: 10.1007/s11033-020-05515-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Amani D, Shakiba E, Motaghi E, Alipanah H, Jalalpourroodsari M, Rashidi M. Psoralidin exerts anti-tumor, anti-angiogenic, and immunostimulatory activities in 4T1 tumor-bearing balb/c mice. Horm Mol Biol Clin Investig 2021. [PMID: 34496167 DOI: 10.1515/hmbci-2021-0028] [Reference Citation Analysis]
2 Maroufi NF, Ashouri N, Mortezania Z, Ashoori Z, Vahedian V, Amirzadeh-Iranaq MT, Fattahi A, Kazemzadeh H, Bizzarri M, Akbarzadeh M, Nejabati HR, Faridvand Y, Rashidi MR, Nouri M. The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor. Pathol Res Pract 2020;216:153226. [PMID: 32987338 DOI: 10.1016/j.prp.2020.153226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
3 Tsai YM, Wu KL, Liu YW, Chang WA, Huang YC, Chang CY, Tsai PH, Liao SH, Hung JY, Hsu YL. Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment via Notch2-Jagged1 Interaction in Lung Cancer. Front Oncol 2021;11:696931. [PMID: 34485133 DOI: 10.3389/fonc.2021.696931] [Reference Citation Analysis]
4 Cocola C, Magnaghi V, Abeni E, Pelucchi P, Martino V, Vilardo L, Piscitelli E, Consiglio A, Grillo G, Mosca E, Gualtierotti R, Mazzaccaro D, La Sala G, Di Pietro C, Palizban M, Liuni S, DePedro G, Morara S, Nano G, Kehler J, Greve B, Noghero A, Marazziti D, Bussolino F, Bellipanni G, D'Agnano I, Götte M, Zucchi I, Reinbold R. Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy. Front Cell Neurosci 2021;15:703431. [PMID: 34867197 DOI: 10.3389/fncel.2021.703431] [Reference Citation Analysis]
5 Eddy K, Shah R, Chen S. Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities. Front Oncol 2020;10:626129. [PMID: 33614507 DOI: 10.3389/fonc.2020.626129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Berry MR, Fan TM. Target-Based Radiosensitization Strategies: Concepts and Companion Animal Model Outlook. Front Oncol 2021;11:768692. [PMID: 34746010 DOI: 10.3389/fonc.2021.768692] [Reference Citation Analysis]
7 Maroufi NF, Amiri M, Dizaji BF, Vahedian V, Akbarzadeh M, Roshanravan N, Haiaty S, Nouri M, Rashidi MR. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells. Eur J Pharmacol 2020;881:173282. [PMID: 32580038 DOI: 10.1016/j.ejphar.2020.173282] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
8 Souza JC, Bastos VC, Pereira NB, Dias AAM, Avelar GF, Gomez RS, Gomes CC. Angiogenesis in patient-derived xenografts of odontogenic myxoma. Int J Exp Pathol 2022. [PMID: 35225401 DOI: 10.1111/iep.12431] [Reference Citation Analysis]
9 Chavoshi H, Poormolaie N, Vahedian V, Kazemzadeh H, Mir A, Nejabati HR, Behroozi J, Isazadeh A, Hajezimian S, Nouri M, Maroufi NF. Vascular mimicry: A potential therapeutic target in breast cancer. Pathology - Research and Practice 2022;234:153922. [DOI: 10.1016/j.prp.2022.153922] [Reference Citation Analysis]
10 Shao Y, Lu B. The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers. Cancer Metastasis Rev 2021. [PMID: 34664157 DOI: 10.1007/s10555-021-10000-8] [Reference Citation Analysis]
11 Pourmohammad P, Maroufi NF, Rashidi M, Vahedian V, Pouremamali F, Faridvand Y, Ghaffari-Novin M, Isazadeh A, Hajazimian S, Nejabati HR, Nouri M. Potential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer. Biochem Genet 2021. [PMID: 34181134 DOI: 10.1007/s10528-021-10104-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Pouremamali F, Vahedian V, Hassani N, Mirzaei S, Pouremamali A, Kazemzadeh H, Faridvand Y, Jafari-gharabaghlou D, Nouri M, Maroufi NF. The role of SOX family in cancer stem cell maintenance: With a focus on SOX2. Pathology - Research and Practice 2022;231:153783. [DOI: 10.1016/j.prp.2022.153783] [Reference Citation Analysis]
13 Kuehlbach C, Hensler S, Mueller MM. Recapitulating the Angiogenic Switch in a Hydrogel-Based 3D In Vitro Tumor-Stroma Model. Bioengineering (Basel) 2021;8:186. [PMID: 34821752 DOI: 10.3390/bioengineering8110186] [Reference Citation Analysis]
14 Shiran MR, Amani D, Ajami A, Jalalpourroodsari M, Khalizadeh M, Rashidi M. Antitumor effects of Auraptene in 4T1 tumor-bearing Balb/c mice. Horm Mol Biol Clin Investig 2021;42:245-52. [PMID: 33675195 DOI: 10.1515/hmbci-2020-0090] [Reference Citation Analysis]
15 Shiran MR, Mahmoudian E, Ajami A, Hosseini SM, Khojasteh A, Rashidi M, Maroufi NF. Effect of Auraptene on angiogenesis in Xenograft model of breast cancer. Horm Mol Biol Clin Investig 2021. [PMID: 34851565 DOI: 10.1515/hmbci-2021-0056] [Reference Citation Analysis]